Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4216584
Max Phase: Preclinical
Molecular Formula: C35H41Cl2N5O8S
Molecular Weight: 762.71
Molecule Type: Small molecule
Associated Items:
ID: ALA4216584
Max Phase: Preclinical
Molecular Formula: C35H41Cl2N5O8S
Molecular Weight: 762.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)c1ccc(OCc2cc(Cl)c(CN3CSC[C@H]3C(=O)N3CCN(C4CC4)c4ccccc43)cc2Cl)nc1
Standard InChI: InChI=1S/C35H41Cl2N5O8S/c36-24-12-22(17-50-31-8-5-20(13-38-31)34(48)39-14-29(44)32(46)33(47)30(45)16-43)25(37)11-21(24)15-40-19-51-18-28(40)35(49)42-10-9-41(23-6-7-23)26-3-1-2-4-27(26)42/h1-5,8,11-13,23,28-30,32-33,43-47H,6-7,9-10,14-19H2,(H,39,48)/t28-,29-,30+,32+,33+/m0/s1
Standard InChI Key: KALNGVGZRIWAOP-KVWIHSIESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 762.71 | Molecular Weight (Monoisotopic): 761.2053 | AlogP: 2.02 | #Rotatable Bonds: 14 |
Polar Surface Area: 179.16 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.63 | CX Basic pKa: 3.55 | CX LogP: 1.59 | CX LogD: 1.59 |
Aromatic Rings: 3 | Heavy Atoms: 51 | QED Weighted: 0.14 | Np Likeness Score: -0.85 |
1. Chen T, Reich NW, Bell N, Finn PD, Rodriguez D, Kohler J, Kozuka K, He L, Spencer AG, Charmot D, Navre M, Carreras CW, Koo-McCoy S, Tabora J, Caldwell JS, Jacobs JW, Lewis JG.. (2018) Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5)., 61 (17): [PMID:30141927] [10.1021/acs.jmedchem.8b00308] |
Source(1):